These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8725869)

  • 21. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.
    Mykkänen L; Haffner SM; Kuusisto J; Pyörälä K; Hales CN; Laakso M
    Diabetologia; 1995 Oct; 38(10):1176-82. PubMed ID: 8690169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
    Haffner SM; Gonzalez C; Mykkänen L; Stern M
    Diabetologia; 1997 Jul; 40(7):830-7. PubMed ID: 9243105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
    Clark A; Matthews DR; Naylor BA; Wells CA; Hosker JP; Turner RC
    Diabetes Res; 1987 Feb; 4(2):51-5. PubMed ID: 2884060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients.
    Lindgren FA; Hartling SG; Dahlquist GG; Binder C; Efendić S; Persson BE
    Diabet Med; 1991; 8(7):638-43. PubMed ID: 1680601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus.
    Deacon CF; Schleser-Mohr S; Ballmann M; Willms B; Conlon JM; Creutzfeldt W
    Acta Endocrinol (Copenh); 1988 Dec; 119(4):549-54. PubMed ID: 3059740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin secretion in obese and non-obese NIDDM.
    Cerasi E; Nesher R; Gadot M; Gross D; Kaiser N
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S27-37. PubMed ID: 8529516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasians in the UK.
    Owens DR; Luzio SD; Coates PA
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S19-24. PubMed ID: 8894476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.
    Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG
    Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperproinsulinaemia and islet dysfunction in the NIDDM-like syndrome of Psammomys obesus.
    Kaiser N; Gadot M; Leibowitz G; Cerasi E; Gross DJ
    Adv Exp Med Biol; 1997; 426():371-8. PubMed ID: 9544296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.